Due to unforeseen circumstances this event has been postponed.
Updated – Monday, October 20, 2025
Revvity Symposium
The Revvity Symposium is designed to foster strategic collaboration between Mizzou and Revvity by showcasing groundbreaking research, exploring emerging trends in science and technology and creating pathways for innovation. Through expert panels, faculty presentations and student engagement, the symposium aims to spark partnerships that accelerate the translation of academic discoveries into real-world solutions, strengthen industry-academic relationships and develop a talent pipeline for the next generation of scientific leaders.
Program of Events
| Time | Programming Event |
|---|---|
| 8:30 – 9 a.m. | Attendee Check-In |
| 9 a.m. | Introduction |
| 9:15 – 9:45 a.m. | Faculty Talks – Dr. Elena Goun, Dr. Henry Wan and Dr. Gary Weisman |
| 9:45 – 10 a.m. | Who is Revvity? |
| 10 – 11 a.m. | Panel 1 – Gene Editing and Synthetic Biology: Emerging Applications (see full description below) |
| 11 – 11:15 a.m. | Break |
| 11:15 – 12:15 p.m. | Panel 2 – How is AI and ML transforming research in the lab? (see full description below) |
| 12:15 – 1:15 p.m. | Lunch – Boxed lunch provided to REGISTERED attendees |
| 1:15 – 2:15 p.m. | Panel 3 – Personalized Medicine: From Preclinical Insights to Clinical Impact (see full description below) |
| 2:15 – 2:30 p.m. | Break |
| 2:30 – 3:30 p.m. | Panel 4 – Preparing the Next Generation of Scientists for Industry Careers (see full description below) |
| 3:30 – 3:45 p.m. | Closing Remarks |
| 3:45 – 4 p.m. | Break |
| 4 – 6 p.m. | Poster Session and Networking Session – McQuinn Atrium |
Panel 1 – Gene Editing and Synthetic Biology: Emerging Applications
Gene editing and synthetic biology are redefining the possibilities for patient care. This panel will explore how innovation and safety can be balanced, the technical and ethical challenges ahead, and what it will take to build public trust in these transformative therapies.
Panel 2 – How is AI and ML transforming research in the lab?
Artificial intelligence and machine learning are reshaping how diagnostics and therapies are developed. Experts will discuss how these tools are used beyond “search,” their role in automating lab workflows, and their potential to accelerate the future of R&D.
Panel 3 – Personalized Medicine: From Preclinical Insights to Clinical Impact
From gene and RNA therapies to regenerative medicine and oncolytic viruses, the next wave of therapeutics is taking shape. This panel will bring academic and industry perspectives together to explore the most promising innovations and the models driving their development.
Panel 4 – Preparing the Next Generation of Scientists for Industry Careers
What’s it really like to build a career in industry after academia? Join scientists who have made the transition as they share their career journeys, day-to-day insights, and advice for students and postdocs preparing to take the leap.
About Revvity
Revvity is a global life sciences and diagnostics company empowering scientists and healthcare innovators to move breakthroughs from the lab to the clinic.
It delivers: life science solutions to accelerate discovery in genomics, cell biology and synthetic biology, diagnostics to advance testing for genetic disorders, infectious diseases and personalized medicine, and powerful analytics and automation to turn complex data into actionable insights.
With operations in 160+ countries and a team of 11,000+, Revvity helps researchers and clinicians advance science, improve health and bring cures to life faster.
For more information, please contact Raheel Mahmood at raheel.mahmood@missouri.edu.